Palisade Bio (PALI) R&D In Process (2021 - 2022)
Palisade Bio (PALI) has disclosed R&D In Process for 2 consecutive years, with -$30.1 million as the latest value for Q4 2022.
- On a quarterly basis, R&D In Process changed N/A to -$30.1 million in Q4 2022 year-over-year; TTM through Dec 2022 was -$60.2 million, a N/A change, with the full-year FY2021 number at $30.1 million, changed N/A from a year prior.
- R&D In Process was -$30.1 million for Q4 2022 at Palisade Bio, roughly flat from -$30.1 million in the prior quarter.
- In the past five years, R&D In Process ranged from a high of $30.1 million in Q2 2021 to a low of -$30.1 million in Q2 2022.